3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
1
Surgery
1
Stress, Psychological
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Postoperative Complications
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Intermittent Fasting
1
Head and Neck Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Breast Cancer Invasive
1
Interventions
X-Rays
6
Specimen Handling
6
Cyclophosphamide
6
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
4
fludarabine
3
Nuclear Medicine Department, Hospital
3
Doxorubicin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
mifamurtide
2
ivosidenib
2
fludarabine phosphate
2
ensartinib
2
cabozantinib
2
Methotrexate
2
Mesna
2
Ifosfamide
2
Gemcitabine
2
Cisplatin
2
trastuzumab deruxtecan
1
tazemetostat
1
talazoparib
1
selinexor
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.